Login / Signup

12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.

Kaishi SatomiHirokazu TakamiShintaro FukushimaSatoshi YamashitaYuko MatsushitaYoichi NakazatoTomonari SuzukiShota TanakaAkitake MukasaNobuhito SaitoMasayuki KanamoriToshihiro KumabeTeiji TominagaKeiichi KobayashiMotoo NaganeToshihiko IuchiKoji YoshimotoKaoru TamuraTaketoshi MaeharaKeiichi SakaiKazuhiko SugiyamaKiyotaka YokogamiHideo TakeshimaMasahiro NonakaAkio AsaiToshikazu UshijimaMasao MatsutaniRyo NishikawaKoichi Ichimura
Published in: Neuro-oncology (2021)
12p gain may predict the presence of malignant components of NGGCTs, and poor prognosis of the patients. It may be associated with early tumorigenesis of CNS GCT.
Keyphrases
  • germ cell
  • poor prognosis
  • long non coding rna
  • end stage renal disease
  • ejection fraction
  • prognostic factors
  • peritoneal dialysis
  • genome wide
  • clinical trial
  • dna methylation
  • open label
  • phase iii